Reed, N <br/><br/>
Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer.  [electronic resource] 

 -  Clinical oncology (Royal College of Radiologists (Great Britain))  05 2020 
 - e145-e153 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1433-2981 
<br/><br/><label>Standard No.: </label>10.1016/j.clon.2019.11.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>Consensus<br/>Disease Management<br/>Drug-Related Side Effects and Adverse Reactions--etiology<br/>Expert Testimony<br/>Humans<br/>Phenylurea Compounds--adverse effects<br/>Quinolines--adverse effects<br/>Thyroid Neoplasms--drug therapy